Treatment of orbital myositis with adalimumab (Humira)

Adams, A.B.; Kazim, M.; Lehman, T.J.A.

Journal of Rheumatology 32(7): 1374-1375

2005


ISSN/ISBN: 0315-162X
PMID: 15996084
Document Number: 588185
Adalimumab is a fully humanized IgG1 monoclonal antibody to tumor necrosis factor-alpha. We describe 2 patients (17 and 13 years of age) with refractory, steroid-dependent, recurrent nonspecific orbital myositis not controlled with standard immunosuppressive medications. Both improved with adalimumab treatment, allowing reduction in corticosteroid dosage without disease flare.

Document emailed within 1 workday
Secure & encrypted payments